Cargando…
Targeting RNA Polymerase I Transcription Activity in Osteosarcoma: Pre-Clinical Molecular and Animal Treatment Studies
The survival rate of patients with osteosarcoma (OS) has not improved over the last 30 years. Mutations in the genes TP53, RB1 and c-Myc frequently occur in OS and enhance RNA Polymerase I (Pol I) activity, thus supporting uncontrolled cancer cell proliferation. We therefore hypothesised that Pol I...
Autores principales: | Kang, Chang-Won, Blackburn, Anneke C., Loh, Amos Hong Pheng, Hong, Kuick Chick, Goh, Jian Yuan, Hein, Nadine, Drygin, Denis, Parish, Chris R., Hannan, Ross D., Hannan, Katherine M., Coupland, Lucy A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10135452/ https://www.ncbi.nlm.nih.gov/pubmed/37189750 http://dx.doi.org/10.3390/biomedicines11041133 |
Ejemplares similares
-
The therapeutic potential of RNA Polymerase I transcription inhibitor, CX-5461, in uterine leiomyosarcoma
por: Kang, Chang-Won, et al.
Publicado: (2022) -
Inhibition of RNA polymerase I transcription initiation by CX-5461 activates non-canonical ATM/ATR signaling
por: Quin, Jaclyn, et al.
Publicado: (2016) -
Inhibition of Pol I Transcription a New Chance in the Fight Against Cancer
por: Hein, Nadine, et al.
Publicado: (2017) -
The Ribosomal Gene Loci—The Power behind the Throne
por: Panov, Konstantin I., et al.
Publicado: (2021) -
rDNA Chromatin Activity Status as a Biomarker of Sensitivity to the RNA Polymerase I Transcription Inhibitor CX-5461
por: Son, Jinbae, et al.
Publicado: (2020)